Lead the Path to Autoimmune Innovation
At the 3rd Cell Therapy for Autoimmune Disease Summit join the 130+ strong community of scientific pioneers, C-suite executives, VPs and directors driving innovative cell therapies across a wealth of autoimmune indications.
Delve into the latest data, share proven strategies and unpack first-hand experiences to propel your pipeline from preclinical innovation to clinical success. Featuring a 80% new speaker faculty, 11 new companies and preclinical and clinical showcases, ensure you are represented at the only meeting translating cell therapy potential in autoimmunity into reality.
Join Us in 2025:
Immerse yourself in 3 days of tailored learning, no matter your stage of development, with our tracked structure now extending to the workshop day. Whether you are pivoting from oncology or are a seasoned expert in autoimmunity, delve into solutions addressing your most pressing challenges.
Deep dive into rapidly emerging in vivo therapies, and how these are reshaping the course for autoimmune pipelines, in our newly added agenda sessions.
Bridge the gap between science and strategy in our search and evaluation pharma insights panel. Align your pipeline expansion with industry developments and uncover new partnership opportunities.
Access a breadth of content, from preclinical and translational to clinical development, to keynote presentations and discussions, to equip your scientific and corporate development teams for therapeutic success.
Empower Your Team to Accelerate Clinical Success:
To maximize your team's take home learnings and enhance cross-functional collaborations, this year's content has been expertly curated across two tracks. Bring representation from C-suite leaders to scientific and business development teams, to fast-track your pipeline progression!
Preclinical & Translational Track
Clinical Track
Who Will You Meet?
Hear It Straight from Your Peers:
This meeting had outstanding, high-quality speakers, with expertise in their areas. It was a collaborative environment with many opportunities to network and discuss
Chief Executive Officer, iCell Gene Therapeutics, Past Attendee
I learned an incredible amount about the space from the summit. It was helpful to hear perspectives from investors, physicians, and researchers, all in one room
Associate Director, Sanguine Bio, Past Attendee
